{"url":"https://lda.senate.gov/api/v1/filings/bc48841b-b644-4660-8a6d-e2d843ea0a7c/","filing_uuid":"bc48841b-b644-4660-8a6d-e2d843ea0a7c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2017,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/bc48841b-b644-4660-8a6d-e2d843ea0a7c/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mark F. Lindsay","dt_posted":"2017-04-20T14:13:39.573000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"499 South Capitol St SW # 600","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":400395867,"url":"https://lda.senate.gov/api/v1/registrants/400395867/","house_registrant_id":null,"name":"BELL & LINDSAY, INC.","description":"Lobbying and Consulting","address_1":"425 3rd St SW # 1250","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARK LINDSAY","contact_telephone":"+1 202-905-7345","dt_updated":"2026-07-29T13:54:27.680662-04:00"},"client":{"id":190143,"url":"https://lda.senate.gov/api/v1/clients/190143/","client_id":404,"name":"AMERITOX","general_description":"A leader in pain medication monitoring and research.","client_government_entity":false,"client_self_select":null,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-06-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Informing about the need for effective prescription drug monitoring to address the growing epidemic of prescription drug abuse.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49748,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":"F","last_name":"LINDSAY","suffix":null,"suffix_display":null},"covered_position":"EOP Office of Administration Director","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}